FLAGYL I.V. RTU IN PLASTIC CONTAINER

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 16 USDMF, 13 CEP/COS, 1 JDMF, 3 EU WC, 15 KDMF, 11 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

FINISHED DOSAGE FORMULATIONS

439 FDF Dossiers, 119 FDA Orange Book, 117 Europe, 16 Canada, 14 Australia, 50 South Africa, 123 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/100ML, INJECTABLE;INJECTION - 500MG/100ML, GEL;TOPICAL - 0.75% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;VAGINAL - 0.75%, GEL;VAGINAL - 1.3%, CREAM;TOPICAL - 0.75%, SUSPENSION;ORAL - 500MG/5ML, GEL;TOPICAL - 1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 7 Kirsch Pharma, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 29 BASF, 2 CD Formulation, 1 Clariant, 17 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 3 Finar, 11 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Lubrizol Life Science Health, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 49 Thickeners and Stabilizers, 45 Coating Systems & Additives, 40 Solubilizers, 37 Direct Compression, 36 Topical, 32 Granulation, 31 Disintegrants & Superdisintegrants, 30 Controlled & Modified Release, 26 Parenteral, 22 Film Formers & Plasticizers, 19 Lubricants & Glidants, 18 Taste Masking, 13 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 59 News #PharmaBuzz

GLOBAL SALES INFORMATION

33 US Medicaid Prescriptions, 65 Regulatory FDF Prices

MARKET PLACE

79 APIs, 40 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 18 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 18890 / DOSAGE - INJECTABLE;INJECTION - 500MG/100ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
METRONIDAZOLE(UNII: 140QMO216E) (METRONIDAZOLE - UNII:140QMO216E)	METRONIDAZOLE	500mg in 100

Inactive Ingredients

Ingredient Name	Cardinal Health	Hospira, Inc.	Baxter Healthcare Corporation	Pfizer Labs, Division of Pfizer Inc
ANHYDROUS CITRIC ACID(XF417D3PSL)
CITRIC ACID MONOHYDRATE(2968PHW8QP)
Sodium Chloride(451W47IQ8X)
Sodium Phosphate, Dibasic Anhydrous(22ADO53M6F)
SODIUM PHOSPHATE, DIBASIC(GR686LBA74)
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS(22ADO53M6F)
WATER(059QF0KO0R)

Setid 2cf52b9d 7010 4126 B442 Dcae2ddc9310 Applno 18890 Form Injectable Injection Dosage 500mg 100ml - Drug Product Composition: FLAGYL I.V. RTU IN PLASTIC CONTAINER